Naveglitazar T33598
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Naveglitazar (LY 519818, LY 9818) is a peroxisome proliferator-activated receptor (PPAR) modulator, which has entered phase II clinical trials for the treatment of type 2 diabetes.
CAS nr:
476436-68-7
Purity:
98%
Molecular Weight:
422,48
SMILES:
O=C(O)[C@@H](OC)CC1=CC=C(OCCCOC2=CC=C(OC3=CC=CC=C3)C=C2)C=C1
Formula:
C25H26O6
Pathway:
Target:
